Research Reports

Q2 FY2026 bookings of $288M, book-to-bill 1.23; record backlog approaching $1.5B, up 8.8% YoY (CEO, CFO)
Q2 revenue $233M, up 4.4% YoY; first-half revenue up 7.1% YoY, record first-half revenue (CEO)
Adjusted EBITDA $30M, margin 12.9%, up 36.3% and +300bps YoY; first-half adjusted EBITDA margin 14.3%, up 400bps YoY (CEO)
Gross margin 26%, down ~130bps YoY due to lower-margin backlog mix (CFO)
Operating expenses down $2M or 2.4% YoY; R&D down $6M or 28% YoY on headcount reductions and efficiency (CFO)
Free cash flow Q2 inflow of ~$46M; first-half free cash flow $41M positive (CEO, CFO)
Net working capital ~$414M, down $61M or 12.9% YoY, lowest since Q1 FY2022; net debt $257M, lowest since FY2022 (CEO)
Cash and equivalents $335M at quarter end; $52M cash from ops in Q2, partially offset by $6M capex and $15M share repurchases (CFO)
Program accelerations pulled ~$30M revenue, $10M adjusted EBITDA, and $30M cash from Q3 into Q2 (CEO)
EAC changes: net adverse $4M in Q2, in line with recent quarters (CEO)
Bookings drivers: scope expansion on missile defense program; design wins in advanced air mobility and space; follow-on awards for US missile, naval, radar/EW platforms; ~$20M awards leveraging common processing architecture and StarLab anti-tamper software (CEO)

FY2026 (full year) : Revenue growth low single digits; adjusted EBITDA margin approaching mid-teens; free cash flow positive for the year. Excludes any further accelerations or upside from Golden Dome/global defense budgets (CEO)
Q3 FY2026: Revenue down YoY absent additional accelerations; adjusted EBITDA margin approaching double digits; free cash flow outflow for the quarter (CEO)
Q4 FY2026: Expected to be highest revenue and highest adjusted EBITDA margin quarter of FY2026 (CEO)

"We delivered Q2 results that were ahead of our expectations, with solid year-over-year growth in backlog, revenue, and adjusted EBITDA and robust free cash flow." (CEO)
"Our ability to accelerate progress on a number of our customers' high-priority programs once again contributed to strong results this quarter, including record first-half revenue." (CEO)
"We maintain our full-year view on FY 2026, which excludes any further accelerations within or into FY 2026 or upside bookings to our plan tied to domestic priorities like Golden Dome, or increased global defense budgets." (CEO)
"We continue to expect to allocate factory capacity in fiscal 2026 to programs with unbilled receivable balances which will help drive free cash flow with minimal impact to revenue." (CFO)
"We believe our continuous improvement in program execution, hardware deliveries, just-in-time material, and appropriately timed payment terms will lead to continued reduction in working capital." (CFO)

Topic: 低利润率积压订单消化进度及收入提前确认
Key points:
- 管理层重申低利润率积压订单的消化周期约为4至12个季度，预计大部分影响将在FY2026至FY2027期间“烧穿”并结束。
- 本季度毛利率下降，管理层认为是积极信号，表明正在消耗低利润率积压；同时新订单利润率符合目标水平。
- 本季度有约3000万美元收入提前确认，正向影响EBITDA约1000万美元（无额外运营支出）。
Mgmt stance: 中性偏乐观——消化进度符合预期，并强调执行良好，但未将提前确认纳入正式指引。

Topic: 低利润率积压对FY2027 EBITDA利润率的影响及EAC调整
Key points:
- 低利润率积压对EBITDA利润率的负面影响每季度递减，因存量积压逐步消化，新订单利润率更高。
- 管理层明确：FY2027中低利润率积压占比将“越来越小”，不应假设每季度影响相同。
- 当季净EAC调整为负约350万美元，属“正常范围”，且剩余老旧项目极少，未来有望转为正值。
Mgmt stance: 中性偏乐观——EAC调整已进入尾声，认为当前水平不会阻碍目标利润率的达成。

Topic: 通用处理架构（CPA）产能爬坡与现金/资本分配
Key points:
- CPA已成功爬坡满足项目需求，部分项目已达满产，另有项目仍处于爬坡期，有进一步成长空间。
- 公司现金余额超3亿美元，目标现金水平为1亿至1.5亿美元；本季进行了少量股票回购。
- 资本分配优先顺序仍是去杠杆（偿还债务）。
Mgmt stance: 中性偏乐观——CPA执行良好，现金充足，但强调去杠杆为当前首要任务。

Topic: SCAR项目停工令影响、国际收入及成本优化进展
Key points:
- 管理层未量化SCAR停工令对收入的影响，但表示已纳入指引，且单一合同占比不足总收入10%。
- 国际业务包含“十几项以上”潜在机会，Golden Dome为重要增长催化剂，但尚未形成有意义的贡献。
- 成本优化（设施整合、自动化）已明显体现在运营支出改善中；未来通过增加班次即可提升产能，无需大量前期投资。
Mgmt stance: 中性偏乐观——对长期目标（低至中20% EBITDA利润率）保持信心，但未给出国际收入具体占比。